LifeMD Stock Forward View - Accumulation Distribution
| LFMD Stock | USD 3.98 0.04 1.02% |
LifeMD's price is influenced by both fundamental reality and narrative momentum. This module focuses on narrative momentum - how the current news cycle around LifeMD Inc is likely to influence price in the short term.
Under current market conditions, the short-cycle RSI for LifeMD is 0, signaling extreme oversold conditions. This extreme reading suggests selling pressure has dominated recent sessions and appears to be due for at least a temporary pause.Momentum
Sell Peaked
Oversold | Overbought |
EPS Estimate Next Quarter 0.0167 | EPS Estimate Current Year 0.14 | EPS Estimate Next Year 0.445 | Wall Street Target Price 9.375 | EPS Estimate Current Quarter 0.0333 |
The summary frames LifeMD's price response to attention shifts and peer coverage. This section summarizes LifeMD's options flow and short interest as sentiment inputs.
Short Interest Metrics for LifeMD
Short interest data for LifeMD is reported twice a month, providing a lagged but useful view of aggregate bearish positioning in LifeMD shares.
200 Day MA 6.5471 | Short Percent 0.1607 | Short Ratio 7.5 | Shares Short Prior Month 5.7 M | 50 Day MA 3.3278 |
RSI Signal: LifeMD
Hype-to-Price Context for LifeMD Inc
Investor sentiment toward LifeMD reflects the aggregated optimism or pessimism of all market participants. Extremes in LifeMD's sentiment have historically preceded significant reversals in price direction.
Overvalued stocks supported by excessive positive sentiment are vulnerable to sharp corrections when reality disappoints. LifeMD's sentiment score helps gauge how much of its current price is justified by optimism alone.
LifeMD Implied Volatility | 5.32 |
LifeMD's implied volatility is a key input in option pricing models such as Black-Scholes. It is the only forward-looking variable in these models, making it the primary driver of option premium changes not explained by price moves in LifeMD's stock.
LifeMD after-hype prediction price | $ 3.86 |
This analysis adds an attention layer to forecasting, technical studies, analyst estimates, and earnings views.
Historical Fundamental Analysis of LifeMD can be used to cross-verify projections for LifeMD. The view supplies historical context for the projection discussion.Rule 16 Overview for current LifeMD contract - Performance Context
Rule 16 applies implied volatility to estimate a daily move of roughly 0.33% across the 2026-03-20 option cycle. This context is informational: with LifeMD near $ 3.98, the daily move estimate is $ 0.0132 .
Open Interest - LifeMD Options (2026-03-20)
Open interest for LifeMD options provides a view of outstanding contracts and broader positioning context.
LifeMD Additional Predictive Modules
Most predictive techniques to examine LifeMD price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for LifeMD using various technical indicators. When you analyze LifeMD charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 204423.0 | 98049.21 |
| Check LifeMD Volatility | Backtest LifeMD | Information Ratio |
LifeMD Trading Date Momentum
| On March 13 2026 LifeMD Inc was traded for 3.98 at the closing time. The top price for the day was 4.22 and the lowest listed price was 3.85 . The trading volume for the day was 1.1 M. The trading history from March 13, 2026 did not cause price change. The trading delta at closing time against the current closing price is 0.00% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare LifeMD to competition |
Other Forecasting Options for LifeMD
Any investor evaluating LifeMD must grapple with the challenge of interpreting LifeMD's price movement accurately. LifeMD Stock price charts typically contain substantial noise that can complicate analysis and lead to poor decisions.LifeMD Related Equities
The following equities are related to LifeMD within the Health Care space and can be used for peer comparison, relative valuation, or portfolio diversification. Comparing LifeMD against peers on metrics such as P/E, margins, and return on equity helps contextualize its positioning and identify relative strengths or weaknesses.
| Risk & Return | Correlation |
LifeMD Market Strength Events
Market strength indicators for LifeMD assess how the stock responds to ongoing changes in market conditions and investor sentiment. By monitoring these indicators, investors can identify the most opportune moments to trade LifeMD Inc.
| Accumulation Distribution | 98049.21 | |||
| Daily Balance Of Power | 0.1081 | |||
| Rate Of Daily Change | 1.01 | |||
| Day Median Price | 4.04 | |||
| Day Typical Price | 4.02 | |||
| Price Action Indicator | -0.04 | |||
| Period Momentum Indicator | 0.04 |
LifeMD Risk Indicators
Risk indicator analysis for LifeMD is a critical component of accurate price forecasting and sound investment decision-making. By identifying how much risk is embedded in LifeMD's investment, investors can decide how to position and protect their exposure.
| Mean Deviation | 4.17 | |||
| Semi Deviation | 3.94 | |||
| Standard Deviation | 5.96 | |||
| Variance | 35.51 | |||
| Downside Variance | 18.12 | |||
| Semi Variance | 15.56 | |||
| Expected Short fall | -6.07 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for LifeMD
Coverage intensity for LifeMD Inc matters because narrative visibility can influence sentiment, participation, and volatility around the name. The stronger process compares story flow with performance, theme classification, and the level of short-term market interest.
Contributor Headline
Latest Perspective From Macroaxis
LifeMD Short Properties
Short sentiment tied to LifeMD Inc matters because heavier bearish pressure can change how quickly future price expectations become unstable. Used correctly, these measures can help investors decide when hedging or timing discipline may matter more than conviction alone.
| Common Stock Shares Outstanding | 45.1 M | |
| Cash And Short Term Investments | 36.8 M |
More Resources for LifeMD Stock Analysis
A comprehensive view of LifeMD Inc starts with financial statements and ratio context. Ratio context helps frame profitability, efficiency, and growth trends for LifeMD Inc Stock. Selected reports below provide context for LifeMD Stock:Historical Fundamental Analysis of LifeMD can be used to cross-verify projections for LifeMD. The view supplies historical context for the projection discussion. Analysis related to LifeMD should be read together with other portfolio and risk tools before capital is reallocated. That is especially important when the goal is to improve the overall mix of instruments already held. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Earnings Share -0.25 | Revenue Per Share | Quarterly Revenue Growth -0.27 | Return On Assets | Return On Equity |
Understanding LifeMD Inc includes distinguishing between market value and book value, where book value reflects LifeMD's accounting equity. LifeMD's market capitalization is 189.41 M. With a P/B ratio of 148.71, the market values LifeMD well above its book equity. Enterprise value stands at 178.17 M. Intrinsic value reflects what LifeMD's fundamentals imply about worth, which may differ from both the trading price and the book figure. Analytical frameworks help reconcile those views.
It is useful to distinguish LifeMD's value from its trading price, which are computed with different methods. For LifeMD, key inputs include a P/B ratio of 148.71, a profit margin of 7.4%, ROE of -131.16%, and revenue of 194.06 M. The quoted price is simply the exchange level where supply meets demand.